Relative moldiness index as predictor of childhood respiratory illness

Stephen J Vesper1, Craig McKinstry, Richard A Haugland

  • 1US Environmental Protection Agency, Cincinnati, OH, USA. vesper.stephen@epa.gov

Insights

A new mold assessment method, the Relative Moldiness Index (RMI), accurately predicts infant respiratory illness, unlike traditional visual inspections. This quantitative PCR-based approach offers better risk assessment for mold exposure in homes.

Area of Science:

  • Environmental health
  • Molecular biology
  • Pediatrics

Background:

  • Traditional visual mold inspections are common but may lack predictive power for health outcomes.
  • Infant respiratory illnesses like wheeze and rhinitis are significant health concerns.
  • Accurate assessment of indoor mold exposure is crucial for public health.

Purpose of the Study:

  • To compare the predictive value of visual mold inspection with a novel mold evaluation method, the Relative Moldiness Index (RMI), for infant respiratory illness.
  • To validate the RMI as a predictor of respiratory conditions in infants.
  • To offer a more reliable method for assessing mold-related health risks in homes.

Main Methods:

  • Collected floor dust samples from 271 homes with infants.
  • Quantified the concentration of 36 mold species using mold-specific quantitative PCR (MSQPCR) to calculate the Relative Moldiness Index (RMI).
  • Classified homes based on visual inspection and RMI, then tracked the development of respiratory illness in infants.

Main Results:

  • Visual mold inspection was not predictive of infant respiratory illness (P=0.27).
  • The RMI, fitted to a logistic function, demonstrated significant predictive value for respiratory illness occurrence.
  • The RMI method allows for nuanced risk assessment based on varying levels of moldiness.

Conclusions:

  • The Relative Moldiness Index (RMI) offers a superior, quantitative method for predicting infant respiratory illness compared to traditional visual mold inspections.
  • This validated RMI approach provides a valuable tool for stakeholders to manage and mitigate mold-related health risks in residential environments.
  • Quantitative PCR-based mold assessment holds promise for improving environmental health evaluations and preventative strategies.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...